A detailed history of First Manhattan CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First Manhattan CO holds 20,670 shares of BMY stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,670
Previous 20,670 -0.0%
Holding current value
$1.1 Million
Previous $858,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $21,131 - $27,819
525 Added 2.61%
20,670 $858,000
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $197,341 - $223,747
-4,113 Reduced 16.96%
20,145 $1.09 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $308,284 - $367,868
-6,359 Reduced 20.77%
24,258 $1.24 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $95,518 - $106,804
-1,650 Reduced 5.11%
30,617 $1.78 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $87,601 - $97,267
-1,375 Reduced 4.09%
32,267 $2.06 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $255,546 - $289,847
-3,889 Reduced 10.36%
33,642 $2.33 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $355,959 - $421,505
5,198 Added 16.08%
37,531 $2.7 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $36 - $21,361
-278 Reduced 0.85%
32,333 $2.3 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $44,806 - $49,347
-617 Reduced 1.86%
32,611 $2.51 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $69,410 - $83,229
-1,129 Reduced 3.29%
33,228 $2.43 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $1.01 Million - $1.18 Million
-18,854 Reduced 35.43%
34,357 $2.14 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $189,580 - $222,069
-3,204 Reduced 5.68%
53,211 $3.15 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $342,609 - $373,102
-5,534 Reduced 8.93%
56,415 $3.77 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $215,997 - $242,933
-3,640 Reduced 5.55%
61,949 $3.91 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $965,066 - $1.09 Million
-16,714 Reduced 20.31%
65,589 $4.07 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $292,318 - $323,927
-5,090 Reduced 5.82%
82,303 $4.96 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $103,774 - $121,322
1,893 Added 2.21%
87,393 $5.14 Million
Q1 2020

May 06, 2020

SELL
$46.4 - $67.43 $146,113 - $212,337
-3,149 Reduced 3.55%
85,500 $4.77 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $4.36 Million - $5.69 Million
88,649 New
88,649 $5.69 Million
Q1 2019

Apr 12, 2019

SELL
$45.12 - $53.8 $2.51 Million - $2.99 Million
-55,601 Closed
0 $0
Q4 2018

Jan 30, 2019

BUY
$48.76 - $63.23 $164,369 - $213,148
3,371 Added 6.45%
55,601 $2.89 Million
Q3 2018

Oct 15, 2018

BUY
$55.19 - $62.25 $410,613 - $463,140
7,440 Added 16.61%
52,230 $3.24 Million
Q2 2018

Aug 01, 2018

SELL
$50.53 - $62.98 $75,491 - $94,092
-1,494 Reduced 3.23%
44,790 $2.48 Million
Q1 2018

Apr 20, 2018

SELL
$59.92 - $68.98 $601,177 - $692,076
-10,033 Reduced 17.82%
46,284 $2.93 Million
Q4 2017

Jan 22, 2018

SELL
$59.94 - $65.35 $14.8 Million - $16.1 Million
-247,025 Reduced 81.43%
56,317 $3.45 Million
Q3 2017

Oct 25, 2017

BUY
$55.23 - $63.74 $16.8 Million - $19.3 Million
303,342
303,342 $19.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.